Pricing Log in Create free account
Friday 6 November 2026 Export RPRX’s income statement to Excel — free account

Royalty Pharma PLC

RPRX Healthcare Biotechnology

Royalty Pharma PLC’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 5.06% from fiscal 2024.

Revenue
+13.3%
EPS
−51.5%
Free cash flow
+364.6%
Total debt
−4.00%

Quarter to September 2026, against a year earlier

67.80 0.23 +0.34%
Market cap
$39.0B
P/E
44.8×
Fwd P/E
27.3×
Dividend yield
1.37%
F-score
5/9
Altman Z
1.61
Beneish M
−2.83
Dividend safety
41/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Royalty Pharma PLC (RPRX) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Royalty Pharma PLC (RPRX) trades at a P/E ratio of 44.8×. Over the past ten years it has ranged from 9.4× (December 2024) to 493× (January 2023); the current reading is higher than 72% of that period. That is above the Biotechnology industry median of 10.3× and above the Healthcare sector median of 25.2×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 21.7× 64.23%
FY2024 13.2× 1.46%
FY2023 13.0× (97.35%)
FY2022 493× 1,160.60%
FY2021 39.1× (5.55%)
FY2020 41.4× (37.81%)
FY2019 66.5× 0.00%
FY2018 66.5× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 38.6× 27.52%
Jun 2026 30.3× 20.04%
Mar 2026 25.2× 16.31%
Dec 2025 21.7× 8.29%
25 more quarters

Against its own ten years

Low 9.4× High 493×
Ten-year median 30.6×
Current reading's percentile 72

P/E ratio against peers

Company P/E ratio
ROIV Roivant Sciences Ltd. compare n/m
BNTX BioNTech SE Sponsored ADR compare n/m
RVMD Revolution Medicines, Inc. compare n/m
INSM Insmed, Inc. compare n/m
ARGX argenex SE compare 29.8×
GMAB Genmab A/S Sponsored ADR compare 41.7×
RPRX Royalty Pharma PLC 44.8×
INCY Incyte Corporation compare 56.3×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 65.9×
Biotechnology industry median 10.3×
Healthcare sector median 25.2×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on RPRX